Hsbc Holdings PLC Sells 9,315 Shares of Teleflex Incorporated (NYSE:TFX)

Hsbc Holdings PLC decreased its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 7.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 122,010 shares of the medical technology company's stock after selling 9,315 shares during the period. Hsbc Holdings PLC owned 0.26% of Teleflex worth $21,724,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Headlands Technologies LLC bought a new position in shares of Teleflex during the 4th quarter worth approximately $29,000. Avior Wealth Management LLC boosted its stake in Teleflex by 81.2% during the fourth quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock worth $50,000 after acquiring an additional 125 shares in the last quarter. IFP Advisors Inc boosted its stake in Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock worth $55,000 after acquiring an additional 217 shares in the last quarter. Exchange Traded Concepts LLC grew its holdings in Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock worth $61,000 after purchasing an additional 94 shares during the period. Finally, R Squared Ltd bought a new stake in Teleflex in the fourth quarter valued at $64,000. Institutional investors and hedge funds own 95.62% of the company's stock.

Teleflex Stock Up 0.8 %

TFX traded up $1.02 during mid-day trading on Friday, reaching $126.89. 209,743 shares of the stock were exchanged, compared to its average volume of 636,290. Teleflex Incorporated has a 1 year low of $124.66 and a 1 year high of $249.91. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The stock has a market capitalization of $5.88 billion, a PE ratio of 25.22, a price-to-earnings-growth ratio of 1.73 and a beta of 1.19. The company has a 50 day moving average price of $136.84 and a two-hundred day moving average price of $171.53.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. The business had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm's quarterly revenue was down 5.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.21 EPS. As a group, research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 1.07%. Teleflex's dividend payout ratio (DPR) is currently 95.77%.

Wall Street Analyst Weigh In

TFX has been the topic of a number of research analyst reports. Mizuho set a $155.00 price objective on shares of Teleflex in a research report on Wednesday, April 16th. StockNews.com lowered Teleflex from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Piper Sandler restated a "neutral" rating and set a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a report on Friday, February 28th. Royal Bank of Canada lowered Teleflex from an "outperform" rating to a "sector perform" rating and lowered their target price for the stock from $220.00 to $155.00 in a research report on Friday, February 28th. Finally, Truist Financial reduced their price target on shares of Teleflex from $149.00 to $140.00 and set a "hold" rating for the company in a research report on Friday, April 11th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $169.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.